Modified proteases that inhibit complement activation

Details for Australian Patent Application No. 2006304804 (hide)

Owner Catalyst Biosciences, Inc.

Inventors Nguyen, Jack; Ruggles, Sandra Waugh; Madison, Edwin L.; Thanos, Christopher D.

Agent Spruson & Ferguson

Pub. Number AU-B-2006304804

PCT Pub. Number WO2007/047995

Priority 60/729,817 21.10.05 US

Filing date 20 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 2 June 2011

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/047995 Priority application(s): WO2007/047995

2 June 2011 Application Accepted

  Published as AU-B-2006304804

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304809-Neural stimulation system and optical monitoring systems and methods

2006304803-Dental and endodontic filling materials and methods